TrialPLoS neglected tropical diseases2023

ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.

Rocio Rivero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.